Analyst Activity – Morgan Stanley Lowers Its Price Target On NYSE:HCP – HCP (NYSE:HCP) to

Analyst Ratings For NYSE:HCP – HCP (NYSE:HCP)

Today, Morgan Stanley lowered its price target on NYSE:HCP – HCP (NYSE:HCP) to per share.

Some recent analyst ratings include

  • 6/1/2018-Raymond James Reiterated Rating of Market Perform.
  • 6/1/2018-Evercore ISI was Downgraded by analysts at Evercore ISI from a “In-Line ➝ Underperform” rating to a “” rating.
  • 5/3/2018-BMO Capital Markets Reiterated Rating of Hold.
  • 3/8/2018-Bank of America Upgrade from a “Neutral ➝ Buy” rating to a “” rating.
  • 2/23/2018-Royal Bank of Canada Reiterated Rating of Hold.

Dividend information for NYSE:HCP – HCP (NYSE:HCP)

NYSE:HCP – HCP (NYSE:HCP) pays an annual dividend of $1.48 with a yield of 6.20% and an average dividend growth of -12.10% based on a 3 Year Average..

Dividend History for NYSE:HCP – HCP (NYSE:HCP)

  • On 4/26/2018 NYSE:HCP – HCP announced a quarterly dividend of $0.37 6.61% with an ex dividend date of 5/4/2018 which will be payable on 5/22/2018.
  • On 2/1/2018 NYSE:HCP – HCP announced a quarterly dividend of $0.37 6.37% with an ex dividend date of 2/14/2018 which will be payable on 3/2/2018.
  • On 10/26/2017 NYSE:HCP – HCP announced a quarterly dividend of $0.37 5.79% with an ex dividend date of 11/3/2017 which will be payable on 11/21/2017.
  • On 7/27/2017 NYSE:HCP – HCP announced a quarterly dividend of $0.37 4.65% with an ex dividend date of 8/3/2017 which will be payable on 8/22/2017.
  • On 4/27/2017 NYSE:HCP – HCP announced a quarterly dividend of $0.37 4.72% with an ex dividend date of 5/4/2017 which will be payable on 5/23/2017.
  • On 2/2/2017 NYSE:HCP – HCP announced a quarterly dividend of $0.37 4.81% with an ex dividend date of 2/13/2017 which will be payable on 3/2/2017.
  • On 11/1/2016 NYSE:HCP – HCP announced a quarterly dividend of $0.37 with an ex dividend date of 11/8/2016 which will be payable on 11/25/2016.

Recent Insider Trading Activity For NYSE:HCP – HCP (NYSE:HCP)
NYSE:HCP – HCP (NYSE:HCP) has insider ownership of 0.14% and institutional ownership of 88.78%.

  • On 5/14/2018 R Kent Griffin Jr, Director, bought 21,100 with an average share price of $23.80 per share and the total transaction amounting to $502,180.00.
  • On 2/14/2018 Kendall K Young, Insider, bought 14,000 with an average share price of $21.91 per share and the total transaction amounting to $306,740.00.
  • On 6/13/2017 Thomas Klaritch, Insider, sold 2,651 with an average share price of $31.53 per share and the total transaction amounting to $83,586.03.
  • On 3/16/2017 Scott A Anderson, CAO, sold 10,000 with an average share price of $29.94 per share and the total transaction amounting to $299,400.00.
  • On 9/7/2016 Thomas D. Kirby, Insider, sold 3,000 with an average share price of $40.24 per share and the total transaction amounting to $120,720.00.
  • On 8/31/2016 Darren A Kowalske, Insider, sold 2,250 with an average share price of $39.20 per share and the total transaction amounting to $88,200.00.
  • On 8/24/2016 Kendall K Young, Insider, sold 9,000 with an average share price of $39.46 per share and the total transaction amounting to $355,140.00.

Recent Trading Activity for NYSE:HCP – HCP (NYSE:HCP)
Shares of NYSE:HCP – HCP closed the previous trading session at 23.86 up +0.34 1.45% with 23.559999465942383 shares trading hands.

An ad to help with our costs